ProHance

NDC 0270-1111 · Bracco Diagnostics Inc

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic namegadoteridol

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)GADOTERIDOL

Strength279.3 mg/mL

Pharmacologic classMagnetic Resonance Contrast Activity [MoA], Paramagnetic Contrast Agent [EPC]

Marketing categoryNDA

Packages

0270-1111-01 — 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-01) / 10 mL in 1 VIAL, SINGLE-DOSE

0270-1111-02 — 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-02) / 15 mL in 1 VIAL, SINGLE-DOSE

0270-1111-03 — 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-03) / 20 mL in 1 VIAL, SINGLE-DOSE

0270-1111-04 — 5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-04) / 5 mL in 1 VIAL, SINGLE-DOSE

0270-1111-70 — 5 VIAL, PHARMACY BULK PACKAGE in 1 BOX (0270-1111-70) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE

0270-1111-85 — 5 VIAL, PHARMACY BULK PACKAGE in 1 BOX (0270-1111-85) / 100 mL in 1 VIAL, PHARMACY BULK PACKAGE

Billed under HCPCS

A9576 — Injection, gadoteridol, (prohance multipack), per ml Medicare Part B payment limit (ASP + 6%): $1.37

A9579 — Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml Medicare Part B payment limit (ASP + 6%): $1.44

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70436-121 — GADOTERIDOL

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.